Table 1.
Compound | Analysis | Effect of Wine Intake (↑, ↓) | |
---|---|---|---|
Targeted | Non-Targeted | ||
Group I: Wine compounds | |||
2-Hydroxyglutaric acid a | + | ↑ | |
2-Methylbutyric acid | + | ↑ | |
2,3-Pentanedione | + | ↑ | |
Diethylmalonate | + | ↑ | |
2-Phenethyl butyrate | + | ↑ | |
2-Phenylethyl hexanoate | + | ↑ | |
Group II: Phenolic metabolites | |||
Benzoic acids | |||
3,5-Dihydroxybenzoic acid | + | ↑ | |
Protocatechuic acid | + | ↑ | |
3-O-Methylgallic acid | + | ↑ | |
Vanillic acid | + | ↑ | |
Syringic acid | + | ↑ | |
Benzoic acid b | + | ↑ | |
Phenylacetic acids | |||
3-Hydroxyphenylacetic acid | + | ↑ | |
Phenylpropionic acids | |||
3-Phenylpropionic acid | + | ↑ | |
3-(3’-Hydroxyphenyl) propionic acid b | + | ↓ | |
Valeric acids | |||
4-Hydroxy-5-(3’-hydroxyphenyl) valeric acid | + | ↑ | |
4-Hydroxy-5-(phenyl) valeric acid | + | + | ↑ |
4-Hydroxy-5-(3’,4’-dihydroxyphenyl) valeric acid | + | ↑ | |
Valerolactones | |||
5-(3’,4’-Dihydroxyphenyl)- γ-valerolactone | + | ↑ | |
5-(3’-Hydroxyphenyl)-γ-valerolactone | + | ↑ | |
Group III: Endogenous metabolites | |||
Xanthine b | + | ↓ | |
Tricarballylic acid | + | ↓ | |
Glutaric acid b | + | ↑ | |
Urobilinogen b | + | ↑ | |
Stercobilin b | + | ↑ | |
Docosahexaenoic acid methyl ester | + | ↑ | |
Deoxycholic acid | + | ↑ | |
Sulfolithocholic acid | + | ↓ | |
Cholesterol sulfate | + | ↑ |
a Confirmed in the wine used in the study; b metabolite identification confirmed with commercial standards in the non-targeted approach.